TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING INCIDENCES OF HEARING LOSS
4.2.2 GROWTH OF ELDERLY/GERIATRIC POPULATION
4.3 RESTRAINTS
4.3.1 HIGH COST AND AFFORDABILITY ISSUES
4.3.2 STIGMA AND SOCIAL ACCEPTANCE
4.4 OPPORTUNITY
4.4.1 RISE IN DISPOSABLE INCOME AND AFFORDABILITY
4.4.2 TECHNOLOGICAL ADVANCEMENTS
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 PORTER’S FIVE FORCES MODEL
5.1.1.1 THREAT OF NEW ENTRANTS
5.1.1.2 BARGAINING POWER OF SUPPLIERS
5.1.1.3 BARGAINING POWER OF BUYERS
5.1.1.4 THREAT OF SUBSTITUTES
5.1.1.5 INDUSTRY RIVALRY
5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET
5.3 OTC HEARING AID MARKET TRENDS
5.4 PAYMENT MODE ANALYSIS BY REGION
6 GLOBAL HEARING AIDS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.1.1 HEARING AID DEVICES
6.1.1.1 BEHIND-THE-EAR (BTE) HEARING AIDS
6.1.1.2 IN-THE-EAR (ITE) HEARING AIDS
6.1.1.3 CANAL HEARING AIDS
6.1.1.4 RECEIVER-IN-THE-EAR (RIE) HEARING AID
6.1.1.5 OTHERS
6.1.2 HEARING IMPLANTS
6.1.2.1 COCHLEAR IMPLANTS
6.1.2.2 BONE-ANCHORED HEARING AIDS (BAHA)
7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS
7.1 INTRODUCTION
7.1.1 SENSORINEURAL HEARING LOSS
7.1.2 CONDUCTIVE HEARING LOSS
8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE
8.1 INTRODUCTION
8.1.1 ADULTS
8.1.2 PEDIATRICS
9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
9.1.1 DIGITAL
9.1.2 ANALOG
10 GLOBAL HEARING AIDS MARKET, BY END USER
10.1 INTRODUCTION
10.1.1 PRIVATE PAY/OUT OF POCKET
10.1.2 THIRD PARTY PAYER
10.1.3 MEDICARE/MEDICAID
11 GLOBAL HEARING AIDS MARKET, BY REGION
11.1 INTRODUCTION
11.1.1 NORTH AMERICA
11.1.1.1 US
11.1.1.2 CANADA
11.1.1.3 MEXICO
11.1.2 EUROPE
11.1.2.1 GERMANY
11.1.2.2 UK
11.1.2.3 FRANCE
11.1.2.4 ITALY
11.1.2.5 SPAIN
11.1.2.6 REST OF EUROPE
11.1.3 ASIA-PACIFIC
11.1.3.1 JAPAN
11.1.3.2 CHINA
11.1.3.3 INDIA
11.1.3.4 AUSTRALIA
11.1.3.5 REST OF ASIA PACIFIC
11.1.4 SOUTH AMERICA
11.1.4.1 BRAZIL
11.1.4.2 COLOMBIA
11.1.4.3 REST OF SOUTH AMERICA
11.1.5 MIDDLE EAST & AFRICA
11.1.5.1 SOUTH AFRICA
11.1.5.2 GCC COUNTRIES
11.1.5.3 REST OF MIDDLE EAST AND AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS, 2023
13 COMPANY PROFILES
13.1 COCHLEAR LIMITED
13.1.1 COMPANY OVERVIEW
13.1.2 PRODUCTS OFFERED
13.1.3 SWOT ANALYSIS
13.1.4 KEY STRATEGY
13.2 GN HEARING A/S
13.2.1 COMPANY OVERVIEW
13.2.2 PRODUCTS OFFERED
13.2.3 SWOT ANALYSIS
13.2.4 KEY STRATEGY
13.3 SONOVA
13.3.1 COMPANY OVERVIEW
13.3.2 PRODUCTS OFFERED
13.3.3 SWOT ANALYSIS
13.3.4 KEY STRATEGY
13.4 WILLIAM DEMANT HOLDING A/S
13.4.1 COMPANY OVERVIEW
13.4.2 PRODUCTS OFFERED
13.4.3 SWOT ANALYSIS
13.4.4 KEY STRATEGY
13.5 STARKEY
13.5.1 COMPANY OVERVIEW
13.5.2 PRODUCTS OFFERED
13.5.3 SWOT ANALYSIS
13.5.4 KEY STRATEGY
13.6 PETROFAC
13.6.1 COMPANY OVERVIEW
13.6.2 PRODUCTS OFFERED
13.6.3 SWOT ANALYSIS
13.6.4 KEY STRATEGY
13.7 HALLIBURTON
13.7.1 COMPANY OVERVIEW
13.7.2 PRODUCTS OFFERED
13.7.3 SWOT ANALYSIS
13.7.4 KEY STRATEGY
13.8 ZOUNDS HEARING
13.8.1 COMPANY OVERVIEW
13.8.2 PRODUCTS OFFERED
13.8.3 SWOT ANALYSIS
13.8.4 KEY STRATEGY
13.9 AUDINA HEARING INSTRUMENTS
13.9.1 COMPANY OVERVIEW
13.9.2 PRODUCTS OFFERED
13.9.3 SWOT ANALYSIS
13.9.4 KEY STRATEGY
13.10 AMPLIFON
13.10.1 COMPANY OVERVIEW
13.10.2 PRODUCTS OFFERED
13.10.3 SWOT ANALYSIS
13.10.4 KEY STRATEGY
14 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 3 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 4 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 5 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 6 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 7 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 8 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 9 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY REGION, 2019–2035 (USD MILLION)
TABLE 10 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 11 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 12 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 13 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 14 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 15 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 16 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 17 US HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 18 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 19 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 20 US HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 21 US HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 22 US HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 23 US HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 24 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 25 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 26 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 27 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 28 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 29 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 30 CANADA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 31 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 32 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 33 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 34 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 35 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 36 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 37 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 38 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 39 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 40 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 41 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 42 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 43 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 44 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 45 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 46 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 47 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 48 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 49 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 50 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 51 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 52 UK HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 53 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 54 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 55 UK HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 56 UK HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 57 UK HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 58 UK HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 59 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 60 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 61 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 62 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 63 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 64 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 65 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 66 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 67 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 68 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 69 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 70 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 71 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 72 ITALY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 73 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 74 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 75 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 76 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 77 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 78 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 79 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 80 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 81 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 82 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 83 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 84 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 85 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 86 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 87 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 88 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 89 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 90 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 91 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 92 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 93 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 94 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 95 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 96 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 97 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 98 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 99 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 100 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 101 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 102 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 103 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 104 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 105 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 106 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 107 CHINA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 108 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 109 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 110 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 111 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 112 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 113 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 114 INDIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 115 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 116 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 117 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 118 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 119 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 120 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 121 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 123 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 124 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 125 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 126 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 129 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 130 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 131 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 132 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 133 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 134 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 135 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 136 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 137 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 138 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 139 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 140 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 141 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 142 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 143 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 144 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 145 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 146 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 147 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 148 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 149 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 150 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 151 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 152 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 153 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 154 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 155 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 156 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 157 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 158 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 159 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 160 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 161 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 162 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 163 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 164 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 165 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 166 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 167 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 168 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 169 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 170 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 171 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 172 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 173 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 174 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 175 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 176 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 177 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 178 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 179 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2019–2035 (USD MILLION)
TABLE 180 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2019–2035 (USD MILLION)
TABLE 181 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2019–2035 (USD MILLION)
TABLE 182 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2019–2035 (USD MILLION)
TABLE 183 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2019–2035 (USD MILLION)
TABLE 184 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2019–2035 (USD MILLION)
TABLE 185 COCHLEAR LIMITED COMPANY: PRODUCTS OFFERED
TABLE 186 GN HEARING A/S: PRODUCTS OFFERED
TABLE 187 SONOVA: PRODUCTS OFFERED
TABLE 188 WILLIAM DEMANT HOLDING A/S.: PRODUCTS OFFERED
TABLE 189 STARKEY: PRODUCTS OFFERED
TABLE 190 PETROFAC PRODUCTS OFFERED
TABLE 191 HALLIBURTON PRODUCTS OFFERED
TABLE 192 ZOUNDS HEARING PRODUCTS OFFERED
TABLE 193 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED
TABLE 194 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL HEARING AIDS MARKET, BY PRODUCT, 2023 (% SHARE)
FIGURE 2 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023 (% SHARE)
FIGURE 3 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE, 2023 (% SHARE)
FIGURE 4 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY, 2023 (% SHARE)
FIGURE 5 GLOBAL HEARING AIDS MARKET, BY END USER, 2023 (% SHARE)
FIGURE 6 GLOBAL HEARING AIDS MARKET MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%)
FIGURE 7 COCHLEAR LIMITED COMPANY: SWOT ANALYSIS
FIGURE 8 GN HEARING A/S: SWOT ANALYSIS
FIGURE 9 SONOVA: SWOT ANALYSIS
FIGURE 10 WILLIAM DEMANT HOLDING A/S.: SWOT ANALYSIS
FIGURE 11 STARKEY: SWOT ANALYSIS
FIGURE 12 PETROFAC SWOT ANALYSIS
FIGURE 13 HALLIBURTON SWOT ANALYSIS
FIGURE 14 ZOUNDS HEARING SWOT ANALYSIS
FIGURE 15 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS
FIGURE 16 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS
